Overview

Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert (FAI)

Status:
Not yet recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
A study to evaluate the safety and efficacy of an FAI insert for the management of subjects with non-infectious uveitis affecting the posterior segment of the eye.
Phase:
Phase 3
Details
Lead Sponsor:
EyePoint Pharmaceuticals, Inc.